What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHSR-1a) agonist developed as a research tool compound for studying GHSR-mediated GH axis signalling. Its high receptor selectivity and minimal off-target activity distinguish it from earlier generation GHRPs in comparative receptor pharmacology research.

Molecular Properties

| Property | Value |

|----------|-------|

| Molecular Formula | C₃₈H₄₉N₉O₅ |

| Molecular Weight | 711.85 g/mol |

| CAS Number | 170851-70-4 |

| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |

GHSR-1a Receptor Binding Research

Binding Affinity Characteristics

Ipamorelin demonstrates high-affinity binding to the GHSR-1a receptor with reported Ki values in the nanomolar range. In vitro radioligand binding assays utilizing [¹²⁵I]-ghrelin displacement methodology have established ipamorelin's competitive binding profile at the orthosteric binding site. The compound exhibits approximately 100-fold selectivity for GHSR-1a compared to other G protein-coupled receptors in panel screening assays.

Receptor Selectivity Profile

Comprehensive receptor binding studies demonstrate ipamorelin's selectivity advantage over first-generation growth hormone releasing peptides. Unlike GHRP-6 and GHRP-2, ipamorelin shows minimal cross-reactivity with histamine H3, dopamine D2, and serotonin 5-HT2C receptors in radioligand competition assays. This selectivity profile makes it particularly valuable for isolating GHSR-1a-specific signalling responses in cellular models.

G Protein-Coupled Signalling Pathways

Primary Signalling Cascade

GHSR-1a activation by ipamorelin initiates Gαq/11-mediated signalling cascades in transfected cell systems. Calcium mobilization assays using fluorescent indicators demonstrate rapid intracellular calcium release following ipamorelin stimulation. The compound exhibits full agonist activity with EC50 values typically ranging from 1-10 nM in calcium flux assays using HEK293 cells expressing human GHSR-1a.

Secondary Messenger Systems

Ipamorelin activation of GHSR-1a triggers phospholipase C (PLC) activation, leading to inositol phosphate accumulation in cell-based assays. Time-course studies reveal peak IP3 formation occurs within 30-60 seconds of receptor stimulation. Additionally, protein kinase C (PKC) activation downstream of diacylglycerol formation contributes to the overall signalling response profile.

cAMP Signalling Interactions

While GHSR-1a primarily couples through Gαq/11 pathways, ipamorelin can modulate adenylyl cyclase activity in certain cellular contexts. Dual signalling studies demonstrate potential Gαs coupling at higher concentrations, though this represents a secondary signalling mode compared to the primary calcium-mobilizing pathway.

Cellular Model Applications

Transfected Cell Systems

HEK293 and CHO cell lines stably expressing human GHSR-1a serve as primary screening platforms for ipamorelin pharmacological characterization. These systems enable precise dose-response relationship establishment and signalling pathway dissection under controlled conditions. Transient transfection protocols allow for rapid screening of receptor variants and mutants.

Primary Cell Models

Hypothalamic cell cultures and pituitary adenoma cell lines provide physiologically relevant contexts for studying ipamorelin's receptor pharmacology. These models retain endogenous GHSR-1a expression patterns and associated signalling machinery, offering insights into native receptor function and regulation.

Enzyme Kinetics and Metabolism

Peptidase Stability

Ipamorelin's modified amino acid composition, including the N-terminal aminoisobutyric acid (Aib) residue and D-amino acid substitutions, confers enhanced stability against peptidase degradation. In vitro enzyme stability assays demonstrate superior half-life compared to natural ghrelin in plasma and tissue homogenates.

Structure-Activity Relationships

Systematic modification studies reveal critical pharmacophore elements for GHSR-1a binding and activation. The D-2-naphthylalanine residue at position 3 and D-phenylalanine at position 4 prove essential for high-affinity receptor interaction. The C-terminal lysine amide contributes to receptor selectivity and activation efficacy.

Research Summary

Ipamorelin represents a valuable research tool for investigating GHSR-1a receptor pharmacology with its selective binding profile, potent agonist activity, and enhanced metabolic stability. Its well-characterized signalling pathways through Gαq/11-mediated calcium mobilization and minimal off-target activity make it ideal for mechanistic studies of growth hormone secretagogue receptor function. The compound's distinct pharmacological profile compared to earlier GHRPs provides researchers with a refined molecular probe for dissecting GHSR-1a-specific cellular responses in various in vitro experimental paradigms.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.